HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of verapamil in the conversion of supraventricular tachycardia in Singapore children.

Abstract
The efficacy of verapamil in the conversion of 47 episodes of supraventricular tachycardia in 22 children was evaluated. The age of the patients ranged from 15 days to 10 years. Tachycardia was the main mode of presentation. Ten out of 22 children had viral infections. Two patients developed mild cardiac failure. Six patients had underlying cardiac abnormalities. Forty-four out of 47 episodes of supraventricular tachycardia were converted to sinus rhythm by a single dose of verapamil (0.11 +/- 0.08 mg/kg). No significant side-effects were observed. Intravenous verapamil is an effective and safe drug for the conversion of supraventricular tachycardia in children.
AuthorsK Y Chan, W C Yip, M P Ng, J S Tay, H B Wong, C L Tan
JournalAnnals of the Academy of Medicine, Singapore (Ann Acad Med Singap) Vol. 16 Issue 2 Pg. 334-6 (Apr 1987) ISSN: 0304-4602 [Print] Singapore
PMID3688811 (Publication Type: Journal Article)
Chemical References
  • Neostigmine
  • Digoxin
  • Propranolol
  • Verapamil
Topics
  • Child
  • Child, Preschool
  • Digoxin (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neostigmine (therapeutic use)
  • Propranolol (therapeutic use)
  • Tachycardia, Supraventricular (drug therapy)
  • Verapamil (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: